perhaps you might be better off asking the ASX or ASIC the same question - re the discrepancy. The company will then need to publish a response.They have never responded to my questions either.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025